MEPSEVII

This brand name is authorized in Austria, Brazil, Estonia, Spain, France, Croatia, Ireland, Italy, Japan, Lithuania, Poland, United States

Active ingredients

The drug MEPSEVII contains one active pharmaceutical ingredient (API):

1 Vestronidase alfa UNII 7XZ4062R17 - VESTRONIDASE ALFA

Vestronidase alfa is a recombinant form of human betaglucuronidase (GUS) and is intended to provide exogenous GUS enzyme for uptake into cellular lysosomes and subsequent catabolism of accumulated glycosaminoglycans (GAGs) in affected tissues. Read about Vestronidase alfa

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MEPSEVII Concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A16AB18		A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AB Enzymes
Discover more medicines within A16AB18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 597321070000117
Country: EE	Ravimiamet	Identifier(s): 1778340
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181301001
Country: FR	Base de données publique des médicaments	Identifier(s): 61759695
Country: IT	Agenzia del Farmaco	Identifier(s): 047006010
Country: JP	医薬品医療機器総合機構	Identifier(s): 3959427A1020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086090
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100410670
Country: US	FDA, National Drug Code	Identifier(s): 69794-001